A color vision test shows good correlation with cone and cone-rod dystrophy biomarkers and may offer a cost-effective replacement for ERG.

HYDERABAD: In a dimly lit court in Gondia, Maharashtra, the air hummed with tension. Six athletes crouched low, their ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced that safety and efficacy ...

It warns: "You need to tell DVLA about some medical conditions as they can affect your driving. You can be fined up to £1,000 ...

Previous research has shown that voretigene neparvovec administered subretinally early in childhood for RPE65-mediated ...

However if you have a medical condition that affects your driving but don't voluntarily give up your licence, you must inform the DVLA, which will decide if you can continue holding a driving licence.

Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...

The US Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to Beacon ...

Viralgen and Axovia are developing an AAV9-based gene therapy for retinal dystrophy in Bardet-Biedl Syndrome (BBS) patients. The therapy aims to stop photoreceptor cell death and vision loss using a ...

He estimates that SNEC, which sees roughly 50 per cent of Singapore’s subsidised patient volume, sees only about 20 per cent to 30 per cent of all people with retinal dystrophy here. The study ...

To avoid disaster, the Government has limits for legal and illegal drugs, so ask your doctor if you’re unsure. But it’s not just prescription drugs that can see you banned from the steering wheel - ...

Viralgen and Axovia Therapeutics are set to form a partnership to progress the development and manufacturing of an adeno-associated virus vector serotype 9 (AAV9)-based gene therapy for retinal ...